focus -WSS

focus

author：Wikipedia 2025-10-03 00:38:28 - browse：24291

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： How one patient went off dialysis — and others can too

hotspot

focus

WSS

House panel takes first step toward fixing drug shortages

FDA seeks to regulate lab

Fed up with FDA, ALS advocates consider a take

Did you have Obamacare on your GOP debate bingo card?

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Paxlovid should be available without a positive Covid test

hotspot

focus

hotspot

Hollywood unions extend contract negotiations for actors

Medicare to pay more for cardiac rehab in hospital outpatient clinics

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Why the quest to eradicate polio has stumbled

Medicare proposal to cover medical devices draws a mixed reaction

Kaiser Permanente unions announce official strike date

After affirmative action ruling, medical educators look to 'holistic review'

The struggle to figure out which patients 'deserve' Wegovy

Walensky prepares to leave CDC — and Congress — behind

Biogen shutters digital health group, ends Apple study, in cost cutting move

focus

Health tech startups drop sharply from 2021 highs

'A game

Why the drug industry's warnings on the IRA's impact fall short

Free Covid tests will again be offered to all U.S. households

Address the ethical violations that led to 'Three Identical Strangers'

FDA advisers vote against ALS treatment from BrainStorm

Wikipedia

hotspot

focus

leisure time